Skip to content
by Legal Desire
SIGN IN GO PRO
Lawyer profile

Greg Van Buiten

Latham & Watkins LLP
Claim this profile
Firm
Latham & Watkins LLP
Practice
capital markets, Capital Markets, corporate
Office
Not stated
Active in the record
2023 to 2026

Deal experience

Deal types
Capital Markets & IPODebt Capital MarketsRestructuring & Insolvency
Sectors
Aerospace & DefenceHealthcare & Life Sciences
Jurisdictions
DelawareUnited States

Deals

4 announced deals in the record
Latham Advises on Scribe Therapeutics’ US$155.51 Million IPO 28 Jul 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 156m Capital Markets
Latham & Watkins Advises on Allogene Therapeutics’ US$200.4 Million Public Offering of Common Stock 20 Apr 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 200m corporate
Latham & Watkins Advises on BridgeBio’s US$500 Million Convertible Senior Notes Offering 27 Feb 2025
Debt Capital Markets Healthcare & Life Sciences Latham & Watkins LLP USD 500m corporate
Latham & Watkins Advises Virgin Orbit in Voluntary Chapter 11 Proceedings 8 Apr 2023
Restructuring & Insolvency Aerospace & Defence Latham & Watkins LLP USD 31.6m capital markets
Deal alerts PRO

Get an email when Greg Van Buiten is named on a newly announced deal.

See Pro plans

Alerts come as one daily email at most.

Pro

Analytics for Greg Van Buiten

The paid plans add analytics for this lawyer, and for every firm and lawyer in the database:

  • Complete deal history, filtered by keyword, deal type, sector and year
  • Deals by year, sector and deal type
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • CSV and Excel export
SEE PLANS SIGN IN
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction